Drug intelligence / Profile preview

Algard

Development stage
Unknown
Lead developer
Rohto Pharmaceutical
Modality
Small Molecules
Administration
Topical, Ophthalmic
01

Overview

Algard is a brand of over-the-counter (OTC) ophthalmic solutions developed and marketed by Rohto Pharmaceutical, primarily indicated for the relief of symptoms associated with allergic conjunctivitis, such as eye itching, redness, and swelling caused by pollen, house dust, or other allergens. The product line includes various formulations, typically combining mast cell stabilizers (e.g., sodium cromoglicate), antihistamines (e.g., chlorpheniramine maleate), and vasoconstrictors (e.g., tetryzoline hydrochloride) or anti-inflammatory agents (e.g., pranoprofen, dipotassium glycyrrhizinate). It is one of the leading allergy eye drop brands in Japan, with specific versions tailored for contact lens users and those requiring high-potency relief.

Brand names
AlgardRohto AlgardAlgard Clear BlockAlgard Clear Block ZAlgard ContactAlgard Clear Mild Z
Other names
Rohto Algard
02

Targets

ADRA1A (α1A)HRH1 (Histamine H1 Receptor)

Beyond the preview

Go deeper on Algard.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Algard.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call